Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.

COVID-19 convalescent plasma (CCP) could improve the clinical outcome of COVID-19 patients when high-titer CCP is administered in early stages of disease. However, CCP donors have a risk profile like first-time donors, pathogen reduction treatment (PRT) may mitigate such risk but should not impact C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hindawi, Salwa, Elgemmezi, Tarek, A. El-Kafrawy, Sherif, Samadani, Hani, Tilmisani, Mayasim, Assiri, Omar, Raml, Mohammad, I. Azhar, Esam, Badawi, Maha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984302/
https://www.ncbi.nlm.nih.gov/pubmed/36922242
http://dx.doi.org/10.1016/j.transci.2023.103688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984302/
https://www.ncbi.nlm.nih.gov/pubmed/36922242
http://dx.doi.org/10.1016/j.transci.2023.103688

Ejemplares similares